Restricted accessResearch articleFirst published online 2024-10-08
Identifying Gaps and Barriers in Alzheimer’s Disease and Related Dementia Research and Management in Low- and Middle-Income Countries: A Survey of Health Professionals and Researchers
The significant increase in Alzheimer’s disease and related dementia prevalence is a global health crisis, acutely impacting low- and lower-middle and upper-middle-income countries (LLMICs/UMICs).
Objective:
The objective of this study is to identify key barriers and gaps in dementia care and research in LLMICs and UMICs.
Methods:
We conducted an international, cross-sectional survey among clinicians and healthcare professionals (n = 249 in 34 countries) across LLMICs and UMICs, exploring patient demographics, use of clinical diagnosis, dementia evaluation, screening/evaluation tools, and care and treatment.
Results:
Significant disparities were found in diagnostic practices, access to assessments, and access to care. On average, clinicians in LLMICs saw more patients, had less time for evaluations, lower use of formal screening and tools, and less access to biomarkers. They were also under-resourced compared to UMICs.
Conclusions:
The findings provide insights for policymakers, healthcare organizations, and researchers to address the complex challenges associated with dementia care in diverse settings. Addressing these challenges requires a multipronged approach involving local, national, and international stakeholders.
NicholsE, SteinmetzJD, VollsetSE, et al.Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health2022; 7: e105–e125.
2.
WimoA, SeeherK, CataldiR, et al.The worldwide costs of dementia in 2019. Alzheimers Dement2023; 19: 2865–2873.
3.
MattapSM, DeviM, McGrattanAM, et al.The economic burden of dementia in low-and middle-income countries (LMICs): a systematic review. BMJ Glob2022; 7: e007409.
4.
WalshS, GoviaI, PetersR, et al.What would a population-level approach to dementia risk reduction look like, and how would it work?Alzheimers Dement2023; 19: 3203–3209.
5.
StitesSD, MidgettS, Mechanic-HamiltonD, et al.Establishing a framework for gathering structural and social determinants of health in Alzheimer’s disease research centers. Gerontologist2022; 62: 694–703.
6.
Al-RousanT, TsoyE, SdPE, et al.Facilitators and barriers to dementia assessment and diagnosis: perspectives from dementia experts within a global health context. Front Neurol2022; 13: 769360.
ParraMA, ButlerS, McGeownWJ, et al.Globalising strategies to meet global challenges: the case of ageing and dementia. J Glob Health2019; 9: 020310.
9.
PersaudA, BhatPS, VentriglioA, et al.Geopolitical determinants of health. Ind Psychiatry J2018; 27: 308–310.
10.
OniTandUnwinN. Why the communicable/non-communicable disease dichotomy is problematic for public health control strategies: implications of multimorbidity for health systems in an era of health transition. Int Health2015; 7: 390–399.
11.
LopezAD, WilliamsTN, LevinA, et al.Remembering the forgotten non-communicable diseases. BMC Med2014; 12: 200.
12.
LivingstonG, HuntleyJ, SommerladA, et al.Dementia prevention, intervention, and care: report of the Lancet Commission. Lancet2020; 396: 413–446.
13.
Llibre-GuerraJJ, HeavenerA, BruckiSMD, et al.A call for clinical trial globalization in Alzheimer’s disease and related dementia. Alzheimers Dement2023; 19: 3210–3221.
14.
SextonC, SnyderHM, ChandrasekaranL, et al.Expanding representation of low and middle income countries in global dementia research: commentary from the Alzheimer’s association. Front Neurol2021; 12: 633777.
15.
OliveiraD, DeckersK, ZhengL, et al.The career development of early-and mid-career researchers in dementia should be a global priority: a call for action. Aging Ment Health2022; 26: 439–441.
16.
JamesT, MukadamN, SommerladA, et al.Culturally tailored therapeutic interventions for people affected by dementia: A systematic review and new conceptual model. Lancet Healthy Longevity2021; 2: e171–e179.
17.
AlladiSandHachinskiV. World dementia: One approach does not fit all. Neurology2018; 91: 264–270.
18.
StephanBCM, PakpahanE, SiervoM, et al.Prediction of dementia risk in low-income and middle-income countries (the 10/66 Study): an independent external validation of existing models. Lancet Global Health2020; 8: e524–e535.
19.
SwafferK. Dementia: Stigma, language, and dementia-friendly. London: Sage Publications Sage UK: 2014, p. 709–716.
20.
JohnstonK, PrestonR, StrivensE, et al.Understandings of dementia in low and middle income countries and amongst indigenous peoples: a systematic review and qualitative meta-synthesis. Aging Ment Health2019; 24: 1183–1195.
World Health Organization. A blueprint for dementia research. 2022.
23.
CataldiR, SachdevPS, ChowdharyN, et al.A WHO blueprint for action to reshape dementia research. Nat Aging2023; 3: 469–471.
24.
LivingstonG, SommerladA, OrgetaV, et al.Dementia prevention, intervention, and care. Lancet2017; 390: 2673–2734.
25.
LongS, BenoistCandWeidnerW. World Alzheimer Report 2023. Reducing dementia risk: never too early, never too late. London: Alzheimer’s Disease International, 2023.
26.
GalvinJE, ToleaMI, MooreC, et al.The Number Symbol Coding Task: A brief measure of executive function to detect dementia and cognitive impairment. PLoS One2020; 15: e0242233.
27.
StoreyJE, RowlandJTJ, ConfortiDA, et al.The Rowland universal dementia assessment scale (RUDAS): a multicultural cognitive assessment scale. Int Psychogeriatr2004; 16: 13–31.
28.
JackCRJr, AlbertMS, KnopmanDS, et al.Introduction to the recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement2011; 7: 257–262.
29.
JackCRJr, BennettDA, BlennowK, et al.NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement2018; 14: 535–562.
30.
Adkins-JacksonPB, GeorgeKM, BesserLM, et al.The structural and social determinants of Alzheimer’s disease related dementias. Alzheimers Dement2023; 19: 3171–3185.
31.
TraniJF, MoodleyJ, MawMTT, et al.Association of multidimensional poverty with dementia in adults aged 50 years or older in South Africa. JAMA Netw Open2022; 5: e224160.
32.
TraniJ-F, ZhuY, ParkS, et al.Multidimensional poverty is associated with dementia among adults in Afghanistan. EClinicalMedicine2023; 58: 101906.
33.
TraniJ-F, ZhuY, ParkS, et al.Is multidimensional poverty associated to dementia risk? The case of older adults in Pakistan. Innov Aging2024; 8: igae007.
